MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation

Cell

Volumn 119, Issue 1, 2004, Pages 75-86

  Fujita, Naoyuki ^a   Jaye, David L ^a   Geigerman, Cissy ^a   Akyildiz, Adil ^a   Mooney, Myesha R ^a   Boss, Jeremy M ^a   Wade, Paul A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; METASTASIS ASSOCIATE 3 PROTEIN; NUCLEOSOME REMODELLING AND DEACETYLASE PROTEIN; PROTEIN; PROTEIN BCL 6; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CELL FATE; CELL LINE; CONTROLLED STUDY; EMBRYO; GERMINAL CENTER; HUMAN; HUMAN CELL; PLASMA CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RNA INTERFERENCE;

EID: 5344280456     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2004.09.014     Document Type: Article

References (54)

1. Abts H., Emmerich M., Miltenyi S., Radbruch A., Tesch H. CD20 positive human B lymphocytes separated with the magnetic cell sorter (MACS) can be induced to proliferation and antibody secretion in vitro. J. Immunol. Methods. 125:1989;19-28
2. Accolla R.S. Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets. J. Exp. Med. 157:1983;1053-1058
3. Ahmad K.F., Melnick A., Lax S., Bouchard D., Liu J., Kiang C.L., Mayer S., Takahashi S., Licht J.D., Prive G.G. Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain. Mol. Cell. 12:2003;1551-1564
4. Bereshchenko O.R., Gu W., Dalla-Favera R. Acetylation inactivates the transcriptional repressor BCL6. Nat. Genet. 32:2002;606-613
5. Bishop G.A., Haxhinasto S.A., Stunz L.L., Hostager B.S. Antigen-specific B-lymphocyte activation. Crit. Rev. Immunol. 23:2003;149-197
6. Boss J.M., Jensen P.E. Transcriptional regulation of the MHC class II antigen presentation pathway. Curr. Opin. Immunol. 15:2003;105-111
7. Bowen N.J., Fujita N., Kajita M., Wade P.A. Mi-2/NuRD. multiple complexes for many purposes Biochim. Biophys. Acta. 1677:2004;52-57
8. Calame K.L., Lin K.I., Tunyaplin C. Regulatory mechanisms that determine the development and function of plasma cells. Annu. Rev. Immunol. 21:2003;205-230
9. Coffee B., Zhang F., Warren S.T., Reines D. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat. Genet. 22:1999;98-101
10. Dhordain P., Albagli O., Lin R.J., Ansieau S., Quief S., Leutz A., Kerckaert J.P., Evans R.M., Leprince D. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc. Natl. Acad. Sci. USA. 94:1997;10762-10767
11. Dhordain P., Lin R.J., Quief S., Lantoine D., Kerckaert J.P., Evans R.M., Albagli O. The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Res. 26:1998;4645-4651
12. Epstein M.A., Achong B.G., Barr Y.M., Zajac B., Henle G., Henle W. Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J. Natl. Cancer Inst. 37:1966;547-559
13. Fujita N., Jaye D.L., Kajita M., Geigerman C., Moreno C.S., Wade P.A. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell. 113:2003;207-219
14. Gazdar A.F., Oie H.K., Kirsch I.R., Hollis G.F. Establishment and characterization of a human plasma cell myeloma culture having a rearranged cellular myc proto-oncogene. Blood. 67:1986;1542-1549
15. Gyory I., Wu J., Fejer G., Seto E., Wright K.L. PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing. Nat. Immunol. 5:2004;299-308
16. Harris N.S. Plasma cell surface antigen on human blood lymphocytes. Nature. 250:1974;507-509
17. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA. 95:1998;2509-2514
18. Huynh K.D., Bardwell V.J. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT. Oncogene. 17:1998;2473-2484
19. Huynh K.D., Fischle W., Verdin E., Bardwell V.J. BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev. 14:2000;1810-1823
20. Ivanov A.I., Nusrat A., Parkos C.A. Endocytosis of epithelial apical junctional proteins by a clathrin-mediated pathway into a unique storage compartment. Mol. Biol. Cell. 15:2004;176-188
21. Jaskelioff M., Peterson C.L. Chromatin and transcription. histones continue to make their marks Nat. Cell Biol. 5:2003;395-399
22. Jaye D.L., Edens H.A., Mazzucchelli L., Parkos C.A. Novel G protein-coupled responses in leukocytes elicited by a chemotactic bacteriophage displaying a cell type-selective binding peptide. J. Immunol. 166:2001;7250-7259
23. Jaye D.L., Nolte F.S., Mazzucchelli L., Geigerman C., Akyildiz A., Parkos C.A. Use of real-time polymerase chain reaction to identify cell- and tissue-type-selective peptides by phage display. Am. J. Pathol. 162:2003;1419-1429
24. Klein G., Giovanella B., Westman A., Stehlin J.S., Mumford D. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology. 5:1975;319-334
25. Landry J., Slama J.T., Sternglanz R. Role of NAD(+) in the deacetylase activity of the SIR2-like proteins. Biochem. Biophys. Res. Commun. 278:2000;685-690
26. Leon R.P., Hedlund T., Meech S.J., Li S., Schaack J., Hunger S.P., Duke R.C., DeGregori J. Adenoviral-mediated gene transfer in lymphocytes. Proc. Natl. Acad. Sci. USA. 95:1998;13159-13164
27. Li J., Wang J., Nawaz Z., Liu J.M., Qin J., Wong J. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 19:2000;4342-4350
28. Lin K.I., Tunyaplin C., Calame K. Transcriptional regulatory cascades controlling plasma cell differentiation. Immunol. Rev. 194:2003;19-28
29. Luo J., Nikolaev A.Y., Imai S., Chen D., Su F., Shiloh A., Guarente L., Gu W. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell. 107:2001;137-148
30. McHeyzer-Williams L.J., Driver D.J., McHeyzer-Williams M.G. Germinal center reaction. Curr. Opin. Hematol. 8:2001;52-59
31. Monod J., Jacob F. Teleonomic mechanisms in cellular metabolism, growth, and differentiation. Cold Spring Harb. Symp. Quant. Biol. 26:1961;389-401
32. Muhlethaler-Mottet A., Otten L.A., Steimle V., Mach B. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16:1997;2851-2860
33. Nagarajan U.M., Bushey A., Boss J.M. Modulation of gene expression by the MHC class II transactivator. J. Immunol. 169:2002;5078-5088
34. Nilsson K., Bennich H., Johansson S.G., Ponten J. Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin. Exp. Immunol. 7:1970;477-489
35. Niu H. The proto-oncogene BCL-6 in normal and malignant B cell development. Hematol. Oncol. 20:2002;155-166
36. Piskurich J.F., Lin K.-I., Lin Y., Wang Y., Ting J.P.-Y., Calame K. BLIMP-1 mediates extinction of major histocompatibility class II transactivator expression in plasma cells. Nat. Immunol. 1:2000;526-532
37. Shaffer A.L., Yu X., He Y., Boldrick J., Chan E.P., Staudt L.M. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity. 13:2000;199-212
38. Shaffer A.L., Lin K.I., Kuo T.C., Yu X., Hurt E.M., Rosenwald A., Giltnane J.M., Yang L., Zhao H., Calame K., Staudt L.M. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity. 17:2002;51-62. a
39. Shaffer A.L., Rosenwald A., Staudt L.M. Lymphoid malignancies. the dark side of B-cell differentiation Nat. Rev. Immunol. 2:2002;920-932. b
40. Shapiro-Shelef M., Lin K.I., McHeyzer-Williams L.J., Liao J., McHeyzer-Williams M.G., Calame K. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity. 19:2003;607-620
41. Slavin S., Strober S. Spontaneous murine B-cell leukaemia. Nature. 272:1978;624-626
42. Tachibana M., Sugimoto K., Fukushima T., Shinkai Y. Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J. Biol. Chem. 276:2001;25309-25317
43. Ting J.P., Trowsdale J. Genetic control of MHC class II expression. Cell. 109(Suppl):2002;S21-S33
44. Underhill C., Qutob M.S., Yee S.P., Torchia J. A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1. J. Biol. Chem. 275:2000;40463-40470
45. Unkeless J.C. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:1979;580-596
46. Urnov F.D., Yee J., Sachs L., Collingwood T.N., Bauer A., Beug H., Shi Y.B., Wolffe A.P. Targeting of N-CoR and histone deacetylase 3 by the oncoprotein v-erbA yields a chromatin infrastructure-dependent transcriptional repression pathway. EMBO J. 19:2000;4074-4090
47. Wang L., Hiebert S.W. TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3. Oncogene. 20:2001;3716-3725
48. Weintraub H., Davis R., Tapscott S., Thayer M., Krause M., Benezra R., Blackwell T.K., Turner D., Rupp R., Hollenberg S., et al. The myoD gene family. nodal point during specification of the muscle cell lineage Science. 251:1991;761-766
49. Wen Y.D., Perissi V., Staszewski L.M., Yang W.M., Krones A., Glass C.K., Rosenfeld M.G., Seto E. The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc. Natl. Acad. Sci. USA. 97:2000;7202-7207
50. Wong C.W., Privalsky M.L. Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6. J. Biol. Chem. 273:1998;27695-27702
51. Ye B.H., Rao P.H., Chaganti R.S., Dalla-Favera R. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res. 53:1993;2732-2735
52. Yoshida M., Kijima M., Akita M., Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265:1990;17174-17179
53. Zech L., Haglund U., Nilsson K., Klein G. Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int. J. Cancer. 17:1976;47-56
54. Zhang H., Okada S., Hatano M., Okabe S., Tokuhisa T. A new functional domain of Bcl6 family that recruits histone deacetylases. Biochim. Biophys. Acta. 1540:2001;188-200